Medical Devices

A unique partnership between the City of Philadelphia, the Eagles, and a nonprofit is creating new hope for thousands awaiting a life-saving kidney transplant.

Portable tissue oxygen monitors, forged in US military R&D, are now in Ukraine to help medics make life-or-limb decisions in real time.

A new, self-administered RNA therapy for hereditary angioedema gains EU approval, promising fewer attacks and greater freedom for thousands of patients.

Global wellness leader Sisram partners with a Fosun Pharma subsidiary to build a major manufacturing hub, aiming to dominate China's booming aesthetics market.

BioAge Labs is developing an oral drug for diabetic macular edema, a breakthrough that could end the need for frequent, invasive eye injections for millions.

An innovative absorbable implant shows promise in helping men regain continence faster after prostate cancer surgery, a major quality-of-life concern.

Amid market dislocation, Heitman closes its largest fund ever, targeting resilient sectors like medical offices and senior housing to deliver strong returns.

A new partnership between Vida Health and RxSaveCard offers employers a way to subsidize pricey weight-loss drugs outside of traditional insurance plans.

A new FDA-cleared device, born from a doctor's personal struggle with epilepsy, aims to prevent seizure injuries and is now widely accessible.

Machina Medical's novel hydrogel barrier, MFUSE, gains FDA clearance, promising to control severe bleeding in seconds and disrupt the hemostasis market.

Amid rising threats, the U.S. Health Department is investing in intelligence-driven cybersecurity to protect critical health systems and patient data.

A new partnership integrates advanced imaging and ablation tech, aiming to revolutionize pain treatment as procedures shift from hospitals to clinics.

For 10 years, McKesson's QCDR has helped oncologists navigate MIPS. Now, new measures aim to elevate patient care and prove the value of treatment.

Ottawa's Design 1st marks three decades with a record year, proving the enduring demand for complex hardware from medical implants to consumer gadgets.

The newly launched Cord Blood Council tackles financial and operational hurdles to strengthen a vital life-saving resource for transplants and future therapies.

With a new CEO known for FDA wins, Light AI pivots from R&D to commercialize its smartphone-based AI diagnostic platform, shaking up its leadership team.

Ascletis Pharma unveils ASC37, a next-gen, once-monthly obesity drug claiming superior potency and convenience, challenging giants like Eli Lilly.

Private equity giant G Square is acquiring Finnish firm Serres, signaling a major shift towards sustainable solutions in the modern operating room.

A Michigan firm is showcasing a new polymer-based sternal closure system, promising better healing and diagnostics. Is this the end for metal implants?

Renowned trial lawyer Robert Ross receives a top award, marking a career defined by record-setting verdicts and a profound commitment to legal service.